These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 1382167)
21. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection. Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329 [TBL] [Abstract][Full Text] [Related]
22. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Morrell NW; Morris KG; Stenmark KR Am J Physiol; 1995 Oct; 269(4 Pt 2):H1186-94. PubMed ID: 7485548 [TBL] [Abstract][Full Text] [Related]
23. Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms. Schwieler JH; Kahan T; Nussberger J; Hjemdahl P Am J Physiol; 1993 Apr; 264(4 Pt 1):E631-7. PubMed ID: 8386457 [TBL] [Abstract][Full Text] [Related]
24. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479 [TBL] [Abstract][Full Text] [Related]
25. Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis. Keidar S; Attias J; Heinrich R; Coleman R; Aviram M Atherosclerosis; 1999 Oct; 146(2):249-57. PubMed ID: 10532681 [TBL] [Abstract][Full Text] [Related]
26. Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system. Hollenberg NK; Fisher ND; Price DA Hypertension; 1998 Sep; 32(3):387-92. PubMed ID: 9740600 [TBL] [Abstract][Full Text] [Related]
27. Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists. Campbell DJ Clin Exp Pharmacol Physiol Suppl; 1996; 3():S125-31. PubMed ID: 8993851 [TBL] [Abstract][Full Text] [Related]
28. Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo. Fernandes L; Fortes ZB; Nigro D; Tostes RC; Santos RA; Catelli De Carvalho MH Hypertension; 2001 Feb; 37(2 Pt 2):703-9. PubMed ID: 11230360 [TBL] [Abstract][Full Text] [Related]
29. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection. Babiker F; Al-Jarallah A; Joseph S PLoS One; 2016; 11(11):e0165777. PubMed ID: 27814397 [TBL] [Abstract][Full Text] [Related]
30. Cognitive enhancing effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on learning and memory. Nade VS; Kawale LA; Valte KD; Shendye NV Indian J Pharmacol; 2015; 47(3):263-9. PubMed ID: 26069362 [TBL] [Abstract][Full Text] [Related]
31. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction. Ahmad M; White R; Tan J; Huang BS; Leenen FH J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146 [TBL] [Abstract][Full Text] [Related]
32. A comparison of the effects of angiotensin-converting enzyme inhibitors with bradykinin, angiotensin II and their specific antagonists on concanavalin A-induced proliferation of mouse T-lymphocytes. Yeung JH Methods Find Exp Clin Pharmacol; 1994 Apr; 16(3):163-72. PubMed ID: 8046949 [TBL] [Abstract][Full Text] [Related]
33. Activation of the brain angiotensin system by in vivo human angiotensin-converting enzyme gene transfer in rats. Nakamura S; Moriguchi A; Morishita R; Yamada K; Nishii T; Tomita N; Ohishi M; Kaneda Y; Higaki J; Ogihara T Hypertension; 1999 Aug; 34(2):302-8. PubMed ID: 10454458 [TBL] [Abstract][Full Text] [Related]
34. Effects of angiotensin-converting enzyme inhibition on arterial, venous and capillary functions in cat skeletal muscle in vivo. Ekelund U Acta Physiol Scand; 1996 Sep; 158(1):29-37. PubMed ID: 8876745 [TBL] [Abstract][Full Text] [Related]
35. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Iyer SN; Chappell MC; Averill DB; Diz DI; Ferrario CM Hypertension; 1998 Feb; 31(2):699-705. PubMed ID: 9461243 [TBL] [Abstract][Full Text] [Related]
36. Angiotensin-converting enzyme inhibition modifies angiotensin but not kinin peptide levels in human atrial tissue. Campbell DJ; Duncan AM; Kladis A Hypertension; 1999 Aug; 34(2):171-5. PubMed ID: 10454436 [TBL] [Abstract][Full Text] [Related]
37. Cardiac protection: evolving role of angiotensin receptor blockers. Califf RM; Cohn JN Am Heart J; 2000 Jan; 139(1 Pt 2):S15-22. PubMed ID: 10618583 [TBL] [Abstract][Full Text] [Related]
38. Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion. Brunner F; Kukovetz WR Circulation; 1996 Oct; 94(7):1752-61. PubMed ID: 8840871 [TBL] [Abstract][Full Text] [Related]
39. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats. Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682 [TBL] [Abstract][Full Text] [Related]
40. Local action of the renin angiotensin system in the porcine ophthalmic circulation: effects of ACE-inhibitors and angiotensin receptor antagonists. Meyer P; Flammer J; Lüscher TF Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):555-62. PubMed ID: 7890486 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]